Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1985 Nov;20(5):511–513. doi: 10.1111/j.1365-2125.1985.tb05110.x

Double-blind trial of flurbiprofen and phenylbutazone in acute gouty arthritis.

R C Butler, D H Goddard, C S Higgens, P Hollingworth, C T Pease, M A Stodell, J T Scott
PMCID: PMC1400723  PMID: 3907678

Abstract

Flurbiprofen has been compared with phenylbutazone in a double-blind study involving 33 patients with acute gout. Patients received either flurbiprofen 400 mg daily for 48 h followed by 200 mg daily, or phenylbutazone 800 mg daily for 48 h followed by 400 mg daily. The drugs were of comparable efficacy, while side-effects were uncommon and relatively mild. Flurbiprofen appears to be a satisfactory alternative to phenylbutazone in the management of acute gouty arthritis.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOARDMAN P. L., HARTDUDLEY F. 208.--INDOMETHACIN IN THE TREATMENT OF ACUTE GOUT. Practitioner. 1965 Apr;194:560–565. [PubMed] [Google Scholar]
  2. BYWATERS E. G. Gout in the time and person of George IV: a case history. Ann Rheum Dis. 1962 Dec;21:325–338. doi: 10.1136/ard.21.4.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Camus J. P., Prier A., Merlet C., Koeger A. C. Traitement de la goutte. Rev Prat. 1983 Oct 1;33(43):2281–2294. [PubMed] [Google Scholar]
  4. Gutman A. B. Treatment of primary gout: the present status. Arthritis Rheum. 1965 Oct;8(5):911–920. doi: 10.1002/art.1780080502. [DOI] [PubMed] [Google Scholar]
  5. Lachin J. M. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials. 1981 Jun;2(2):93–113. doi: 10.1016/0197-2456(81)90001-5. [DOI] [PubMed] [Google Scholar]
  6. Reardon J. A., Stockman A., Darlington L. G., Scott J. T. Double-blind trial of feprazone and phenylbutazone in acute gout. Curr Med Res Opin. 1980;6(7):445–448. doi: 10.1185/03007998009109465. [DOI] [PubMed] [Google Scholar]
  7. Siegmeth W., Placheta P. Doppelblindstudie: Ketoprofen gegen Phenylbutazon bei akuter Gichtarthritis. Wien Klin Wochenschr. 1976 Sep 3;88(16):535–537. [PubMed] [Google Scholar]
  8. Smyth C. J., Percy J. S. Comparison of indomethacin and phenylbutazone in acute gout. Ann Rheum Dis. 1973 Jul;32(4):351–353. doi: 10.1136/ard.32.4.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Sturge R. A., Scott J. T., Hamilton E. B., Liyanage S. P., Dixon A. S., Davies J., Engler C. Multicentre trial of naproxen and phenylbutazone in acute gout. Ann Rheum Dis. 1977 Feb;36(1):80–82. doi: 10.1136/ard.36.1.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Weiner G. I., White S. R., Weitzner R. I., Rubinstein H. M. Double-blind study of fenoprofen versus phenylbutazone in acute gouty arthritis. Arthritis Rheum. 1979 Apr;22(4):425–426. doi: 10.1002/art.1780220420. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES